UPMSP Intermediate Biology study materials
UPMSP Intermediate Biology study resources

A 12-Day Fever, a Positive Widal and a Village Laboratory

UPMSP Intermediate Biology · Put your knowledge to work in context.

All case studies

A 12-Day Fever, a Positive Widal and a Village Laboratory

A 24-year-old man from a village presents with 12 days of fever rising in steps to 39.5°C each evening, headache, constipation, a coated tongue, and a pulse of 84/min despite the high fever. The nearest laboratory reports Widal: Salmonella typhi O 1:160 and H 1:160. He was vaccinated against typhoid two years ago and had an undiagnosed febrile illness eight months ago. Blood culture is not available locally; the nearest facility is 40 km away. Because he is unwell, the local doctor starts oral ciprofloxacin and plans to review in a week. There are no rose spots and no abdominal guarding, and the spleen is just palpable. He works at a food stall and cannot afford repeated tests or travel.

1. Interpret the Widal result in this patient. Why can a single O 1:160 and H 1:160 not confirm typhoid here?

Read the worked answer

Widal detects agglutinating antibodies against the somatic O and flagellar H antigens of Salmonella. A titre of 1:160 is often quoted as a cut-off, but in areas where typhoid is endemic, healthy people and people with past exposure frequently carry titres at or above this level, so a single reading has poor specificity.

Three features of this history weaken it further. First, he was vaccinated two years ago, and vaccine-induced antibodies can persist or rise anamnestically. Second, an undiagnosed febrile illness eight months ago may have been typhoid or another Salmonella infection, leaving residual H antibodies, which are long-lived compared with O antibodies and are more affected by vaccination. Third, a single sample cannot distinguish a current infection from old antibody; the useful finding is a four-fold rise between paired sera taken 7–14 days apart.

Cross-reactions with other enterobacterial antigens can also produce false positives. The correct reading is that the Widal is compatible with typhoid but neither proves nor excludes it; the clinical picture - step-ladder fever, coated tongue, constipation, relative bradycardia - supplies most of the diagnostic weight, while confirmation needs culture or a molecular test.

2. At day 12, and with ciprofloxacin already started, what is the best confirmatory test and what practical steps improve its yield?

Read the worked answer

Blood culture is the standard, but its sensitivity is highest in the first week, when bacteraemia is greatest, and falls after about day 10; recent antibiotics reduce it further. At day 12 the realistic options are clot culture, bone marrow culture, or a molecular test such as PCR.

Bone marrow culture is the most sensitive test and remains positive even after antibiotics have been started, because the organism persists in macrophages. It requires a trained operator and sterile technique, which is why it is often reserved for exactly this situation - conflicting serology and prior antibiotics.

If marrow aspiration cannot be arranged, blood should still be taken for culture and clot culture immediately before the next antibiotic dose, with an adequate volume (5–10 mL in an adult) and inoculated into the correct medium. Stool and urine culture become more useful in the second and third weeks. None of this should delay treatment: cultures are for confirmation, resistance testing and public health, not for deciding whether to treat. A food handler also needs clearance advice, since he can be a source of outbreaks.

3. Critique the doctor's antibiotic plan for this patient and state what should be monitored instead of waiting a week.

Read the worked answer

Starting empirical treatment is correct; waiting for culture is not. What needs criticism is the choice of ciprofloxacin and the one-week review.

Fluoroquinolone resistance in Salmonella typhi is widespread in India, so ciprofloxacin is no longer a reliable first-line agent for a seriously ill patient with no sensitivity data. A third-generation cephalosporin such as ceftriaxone, or azithromycin where resistance patterns allow, is a more defensible empirical choice, with the regimen adjusted once susceptibility is known. If the patient is vomiting or looks toxic, the drug should be given intravenously rather than orally.

A week is too long to reassess. Patients on appropriate treatment usually improve in 3–5 days; persistent fever at 72–96 hours suggests resistance, an undrained focus or a different diagnosis. He should be reviewed daily and warned to return at once if abdominal pain becomes sudden and severe, the abdomen becomes rigid, the temperature falls while the pulse rises, or there is bleeding per rectum - all of which point to intestinal perforation or haemorrhage, the classic third-week complications.